Broccoli Flower.

Glucoraphanin in broccoli is inert until myrosinase cleaves its thioglucoside bond to release sulforaphane. Cooking destroys the plant's own myrosinase, so added enzyme is what converts the stored glucosinolate.

Glucoraphanin is the dominant glucosinolate the broccoli head stores, and added glucoraphanin raises the substrate pool that myrosinase or gut bacteria convert.

Sulforaphane is the isothiocyanate released when broccoli glucoraphanin is hydrolysed. Supplying it directly bypasses the conversion step the vegetable depends on.

Ascorbate acts as a cofactor for myrosinase and shifts the hydrolysis of glucoraphanin toward the isothiocyanate rather than the nitrile. Broccoli itself carries ascorbate, which is part of why fresh tissue converts well.

Broccoli glucobrassicin breaks down to indole-3-carbinol, which condenses in stomach acid to diindolylmethane. Taking DIM supplies the same end product the vegetable route arrives at.

Glucosinolate breakdown yields thiocyanate, which competes with iodide for the sodium iodide symporter that concentrates iodide in thyroid tissue. Large brassica intakes matter most where iodine intake is already low.

Broccoli is one of the richest dietary sources of phylloquinone, the cofactor for gamma carboxylation of clotting factors. Its intake adds to any supplemental vitamin K1 in the same formula.

Sulforaphane from broccoli raises transcription of glutathione peroxidase and thioredoxin reductase, and both of those enzymes need selenium at their active site. Induction without selenium supply leaves the enzymes incomplete.

Isothiocyanates from broccoli are conjugated to glutathione and leave by the mercapturate route, and they also raise glutathione synthesis. NAC supplies the cysteine that is rate limiting for that synthesis.

Isothiocyanates react rapidly with the thiol of glutathione, and that conjugate is then processed through the mercapturic acid pathway to the N-acetylcysteine conjugate found in urine. Glutathione is therefore both the handling route for sulforaphane and one of the things whose synthesis enzymes it upregulates. The chemistry is settled. The net effect of adding oral glutathione is not established.

Glutathione is a tripeptide of glutamate, cysteine and glycine, and cysteine availability sets the rate at which it is made. Since isothiocyanate handling consumes glutathione, cysteine supply sits directly upstream of that route. Established biochemistry rather than a combination result.

Glutathione synthetase attaches glycine to gamma-glutamylcysteine to complete the tripeptide. Cysteine usually limits the rate, but glycine is required stoichiometrically. This is textbook pathway biochemistry.

Sulforaphane modifies cysteine residues on Keap1, releasing Nrf2 to drive transcription of phase II enzymes. Alpha lipoic acid is described as acting on the same transcriptional response along with its dithiolane redox cycling. Combining two activators of one pathway is common formulation practice. Whether the effects add in people is not established here.

Silymarin and sulforaphane both appear in the literature as inducers of glutathione-related and conjugating enzymes. Blends stack them for that shared positioning. The individual mechanisms are described. The combination is convention rather than measured.

Curcumin's Michael acceptor groups react with cysteine thiols on Keap1 in much the same way sulforaphane's isothiocyanate group does. Products stack the two for that reason. Two electrophiles working one sensor protein may compete for the same cysteine residues as easily as they add, and no combination data settles it here.

EGCG and sulforaphane are the two most studied dietary inducers of conjugating enzyme expression and are frequently combined in botanical antioxidant blends. Each has its own separate literature. The combination is formulation practice.

Calcium D-glucarate is converted to glucaro-1,4-lactone, which inhibits beta-glucuronidase and reduces deconjugation in the gut. Sulforaphane works on the glutathione conjugation side. The two touch different arms of phase II handling, which is why blends pair them, and the pairing is mechanistic rather than measured.

Plant myrosinase is heat-labile, so dried and milled floret powder often carries the glucosinolate without the enzyme that opens it. Several gut bacteria including lactobacilli express thioglucosidase activity that performs the conversion in the colon, though at lower and more variable yield than the plant enzyme does in the upper gut. This is why conversion differs so much between people.

When myrosinase is absent from the food matrix, the gut microbial community becomes the only route from glucoraphanin to sulforaphane. Studies of urinary isothiocyanate metabolites show wide between-person variation attributed to that microbial step. Which specific strains matter most has not been settled.

Three-day broccoli sprouts contain glucoraphanin at many times the concentration found in mature heads, which is why extract manufacturers use sprouts rather than florets. Combining floret powder with a sprout extract raises the glucosinolate load per serving. The concentration difference between the two tissues is well documented in the food composition literature.

Inulin shifts colonic populations toward bifidobacteria and lactobacilli, some of which express the glucosinolate-hydrolysing activity. That makes it plausible support for the microbial conversion route. The step is mechanistic and the size of any effect on isothiocyanate yield is not established.